Serological Test News and Research

RSS
A cost-effective scalable production of SARS-CoV-2 RBD in yeast

A cost-effective scalable production of SARS-CoV-2 RBD in yeast

Seroconversion marks recovery from COVID-19

Seroconversion marks recovery from COVID-19

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

SARS-CoV-2 exposure five times more likely among Black and Hispanic pregnant women

SARS-CoV-2 exposure five times more likely among Black and Hispanic pregnant women

Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity

Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity

MP Biomedicals and A*STAR jointly develop rapid antibody test kit for COVID-19

MP Biomedicals and A*STAR jointly develop rapid antibody test kit for COVID-19

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

BATM provides business and trading update

BATM provides business and trading update

Seroprevalence of IgM and IgG against SARS-CoV-2 in China

Seroprevalence of IgM and IgG against SARS-CoV-2 in China

Siemens receives FDA approval for SARS-CoV-2 antibody test

Siemens receives FDA approval for SARS-CoV-2 antibody test

At-home finger prick COVID-19 antibody testing

At-home finger prick COVID-19 antibody testing

ELISA and CLIA antibody tests for SARS-CoV-2 perform best in terms of sensitivity

ELISA and CLIA antibody tests for SARS-CoV-2 perform best in terms of sensitivity

SMART researchers awarded NMRC funding to develop rapid paper-based COVID-19 tests

SMART researchers awarded NMRC funding to develop rapid paper-based COVID-19 tests

Study demonstrates dynamic and broad-scale immune alterations in COVID-19 patient

Study demonstrates dynamic and broad-scale immune alterations in COVID-19 patient

New antibody test to identify individuals infected with COVID-19 virus

New antibody test to identify individuals infected with COVID-19 virus

Antibodies to COVID-19 present in only 2 to 3 percent of population

Antibodies to COVID-19 present in only 2 to 3 percent of population

UC San Diego Health launches serological tests to detect past exposure to novel coronavirus

UC San Diego Health launches serological tests to detect past exposure to novel coronavirus

Study identifies two new viruses in Brazilian patients with suspected dengue

Study identifies two new viruses in Brazilian patients with suspected dengue

New blood test for antibodies in COVID-19 infected

New blood test for antibodies in COVID-19 infected

Immunizing with plasma to fight against COVID-19

Immunizing with plasma to fight against COVID-19